Anantharam, Vellareddy <br/><br/>
Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells.  [electronic resource] 

 -  Neurotoxicology  Sep 2007 
 - 988-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0161-813X 
<br/><br/><label>Standard No.: </label>10.1016/j.neuro.2007.08.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenylpyridinium--antagonists & inhibitors<br/>Animals<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Caspases--metabolism<br/>Cell Survival--drug effects<br/>DNA Fragmentation--drug effects<br/>Dopamine--physiology<br/>Dopamine Agents--toxicity<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--pharmacology<br/>MPTP Poisoning--metabolism<br/>Membrane Glycoproteins--genetics<br/>Mesencephalon--cytology<br/>NADPH Oxidase 2<br/>NADPH Oxidases--antagonists & inhibitors<br/>Neurons--drug effects<br/>Organic Chemicals<br/>Oxidative Stress--drug effects<br/>Phosphoproteins--genetics<br/>Rats<br/>Reactive Oxygen Species--metabolism